Translating ECHOS2 Into an mHealth Platform (ECHOS2)
Childhood Cancer, Cardiac Toxicity, Pediatric Cancer
About this trial
This is an interventional supportive care trial for Childhood Cancer focused on measuring Anthracyclines, cardiotoxic therapy, chest radiation, mHealth, childhood cancer survivor, motivational interviewing
Eligibility Criteria
Inclusion Criteria: 18 years of age or older Diagnosed with cancer at age 17 or younger 2 or more years after completion of cancer therapy Receipt of cardiotoxic therapy (Any dose of anthracycline or 15 Gy chest radiation involving cardiac structures) No history of cardiomyopathy Have not received an echocardiogram in the past 5 years
Sites / Locations
- Washington University School of MedicineRecruiting
Arms of the Study
Arm 1
Experimental
Computerized Intervention Authoring Software (CIAS)
Participants will be provided with a link to begin the study following consent, and the link will direct the participants to a baseline survey. At the end of the survey, participants will be automatically redirected to Computerized Intervention Authoring Software (CIAS). Participants will be encouraged to complete 2 sessions in CIAS, approximately 1 week apart. After completing the second session, CIAS will automatically redirect the participants to a post-test survey. Approximately 30 days after completing the second session, participants will be invited to complete a 30 day follow-up survey.